Credit Industriel ET Commercial Has $2.22 Million Stake in LENSAR, Inc. $LNSR

Key Points

• Credit Industriel ET Commercial has increased its stake in LENSAR, Inc. by 98.4% in the second quarter, now owning 1.43% of the company valued at $2.22 million.
• LENSAR's average stock rating is currently "Reduce" with an average target price of $15.00, while analysts have issued a "sell (d-)" rating.
• The company reported a quarterly loss with earnings per share of ($0.15), missing analyst estimates and reflecting a negative net margin of 84.49%.

Credit Industriel ET Commercial boosted its position in shares of LENSAR, Inc. (NASDAQ:LNSR - Free Report) by 98.4% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 168,600 shares of the company's stock after acquiring an additional 83,600 shares during the period. Credit Industriel ET Commercial owned 1.43% of LENSAR worth $2,220,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Gabelli Funds LLC acquired a new position in LENSAR during the 1st quarter worth $191,000. PenderFund Capital Management Ltd. acquired a new position in LENSAR during the 1st quarter worth $236,000. Nuveen LLC acquired a new position in LENSAR during the 1st quarter worth $252,000. Acadian Asset Management LLC acquired a new position in LENSAR during the 1st quarter worth $257,000. Finally, Cubist Systematic Strategies LLC acquired a new position in LENSAR during the 1st quarter worth $369,000. Institutional investors and hedge funds own 40.15% of the company's stock.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reissued a "sell (d-)" rating on shares of LENSAR in a research report on Wednesday, October 8th. Two investment analysts have rated the stock with a Hold rating and one has given a Sell rating to the company. According to MarketBeat, LENSAR presently has an average rating of "Reduce" and an average target price of $15.00.

LENSAR Stock Performance

Shares of LNSR opened at $11.97 on Tuesday. The company has a 50-day simple moving average of $12.41 and a 200-day simple moving average of $13.04. The firm has a market capitalization of $142.92 million, a P/E ratio of -2.84 and a beta of 0.49. LENSAR, Inc. has a 52 week low of $4.79 and a 52 week high of $17.31.

LENSAR (NASDAQ:LNSR - Get Free Report) last announced its quarterly earnings data on Thursday, August 7th. The company reported ($0.15) EPS for the quarter, missing analysts' consensus estimates of ($0.08) by ($0.07). The company had revenue of $11.36 million for the quarter, compared to analyst estimates of $16.55 million. LENSAR had a negative net margin of 84.49% and a negative return on equity of 737.30%.

About LENSAR

LENSAR, Inc, a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision.

Want to see what other hedge funds are holding LNSR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LENSAR, Inc. (NASDAQ:LNSR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.